Drug intelligence / Profile preview

Rheumowin forte

Development stage
Unknown
Lead developer
SKM Siddha and Ayurveda Company
Modality
Small Molecules
Administration
Oral
01

Overview

Rheumowin forte is a traditional herbal formulation developed and marketed by SKM Siddha and Ayurveda Company (India) Private Limited. It is an exclusive blend of nine natural herbs, including Ashwagandha, Bala (Sida cordifolia), Nirgundi (Vitex negundo), Kshudra Agnimantha (Clerodendrum inerme), Siddeswara (Delonix elata), Kalamegha (Andrographis paniculata), and Kungilia parpam (a classical Siddha medicine). The product is indicated for the management of rheumatic and musculoskeletal conditions, providing relief from joint disorders, back pain, knee pain, and various inflammatory joint conditions. It works by protecting the synovial membrane from inflammation, reducing joint pain and swelling, improving mobility and joint flexibility, and enhancing synovial fluid production. Marketed as a 100% natural product, it possesses anti-inflammatory and analgesic properties and is available as 550mg tablets.

Brand names
Rheumowin forteRheumowin
Other names
Rheumowin

Beyond the preview

Go deeper on Rheumowin forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheumowin forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call